The IN.PACT DEEP Clinical Drug-Coated Balloon Trial: 5-Year Outcomes

• Published in: JACC. Cardiovascular interventions Vol. 13; no. 4; p. 431
• Main Authors: Zeller, Thomas, Micari, Antonio, Scheinert, Dierk, Baumgartner, Iris, Bosiers, Marc, Vermassen, Frank E G, Banyai, Martin, Shishehbor, Mehdi H, Wang, Hong, Brodmann, Marianne
• Format: Journal Article
• Language: English
• Published: United States 24.02.2020
• Subjects: Aged; Aged, 80 and over; Amputation; Angioplasty, Balloon - adverse effects; Angioplasty, Balloon - instrumentation; Angioplasty, Balloon - mortality; Cardiovascular Agents - administration & dosage; Cardiovascular Agents - adverse effects; Coated Materials, Biocompatible; Critical Illness; Equipment Design; Europe; Female; Humans; Ischemia - diagnostic imaging; Ischemia - mortality; Ischemia - physiopathology; Ischemia - therapy; Limb Salvage; Male; Middle Aged; Paclitaxel - administration & dosage; Paclitaxel - adverse effects; Peripheral Arterial Disease - diagnostic imaging; Peripheral Arterial Disease - mortality; Peripheral Arterial Disease - physiopathology; Peripheral Arterial Disease - therapy; Prospective Studies; Recurrence; Risk Factors; Time Factors; Treatment Outcome; Vascular Patency; Europe; amputation; paclitaxel; IN.PACT DEEP; infrapopliteal; CD-TLR; mortality; drug-coated balloon

The goal of this study was to evaluate the 5-year follow-up data of the IN.PACT DEEP (Randomized IN.PACT Amphirion Drug-Coated Balloon [DCB] vs. Standard Percutaneous Transluminal Angioplasty [PTA] for the Treatment of Below-the-Knee Critical Limb Ischemia [CLI]) trial. Initial studies from randomiz...